1. Market Research
  2. > Pathology
About 100 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Chromatography Resin Market by Type, Technique, Application, Region - Global Forecast to 2024

  • $ 4950
  • December 2019
  • 172 pages

MarketsandMarkets™ is the world' s largest revenue impact company, serving over ## customers. ##% of the top ##, ## companies globally rely on us for identifying new high growth and niche revenue opportunities.

  • Lymphoma
  • Pharmaceutical
  • GE Healthcare Limited
  • Merck & Co., Inc.
  • Repligen Corporation

Cell Counting Market by Product, Cancer, Stem Cell Research, End User - Global Forecast to 2025

  • $ 4950
  • June 2020
  • 248 pages

As per GLOBOCAN 2018, Germany registered ##, ## new cases of leukemia and ##, ## new cases of lymphoma.

  • Hematology Instrument
  • Laboratory Equipment
  • Lymphoma
  • North America
  • United States

mHealth Solutions Market by Connected Devices, Apps, Services - Global Forecast to 2025

  • $ 4950
  • February 2020
  • 290 pages

(US) FOCUS ON LYMPHOMA APP CHEMO BRAIN DOC NOTES AMERICAN SOCIETY OF CLINICAL ONCOLOGY (US) CARE ZONE, INC.

  • Application
  • Healthcare
  • Lymphoma
  • North America
  • United States

Humanized Mouse and Rat Model Market by Type, Application & End User - Global Forecast to 2022

  • $ 4950
  • March 2018
  • 191 pages

In addition, GTL mice do not develop thymic lymphomas as is commonly observed in NOD/ SCID models.

  • Lymphoma
  • Pharmaceutical
  • North America
  • United States
  • Horizon Discovery

Breast Cancer Liquid Biopsy Market by Circulating Biomarkers, Region, End User, Investments, Market Dynamics, Platform Comparison, Competitive Landscape - Global Forecasts to 2022

  • $ 4950
  • August 2018
  • 83 pages

lymphoma, thyroid cancer, breast cancer, melanoma, GIST, colon, and lung cancer monitoring for common mutations. ctDNA has found significant use as it provides faster detection than conventional techniques, such as CT scans and other imaging technologies.

  • Genetic Testing
  • Lymphoma
  • United States
  • Market Size
  • Biocept, Inc.

Endoscope Reprocessing Market by Product, End User - Global Forecast to 2022

  • $ 4950
  • October 2017
  • 157 pages

MarketsandMarkets is a global market research and consulting company.

  • Endoscope
  • Hospital
  • Infection Control
  • Cantel Medical Corp.
  • Olympus Corporation

Patient Derived Xenograft/PDX Models Market by Type, Tumor Type, Application, End User - Global Forecast to 2022

  • $ 4950
  • September 2017
  • 155 pages

Hematological tumor models include leukemia, and lymphoma ##.

  • Laboratory
  • Lymphoma
  • Charles River Laboratories International, Inc.
  • Horizon Discovery
  • WuXi AppTec Co.

Hemato Oncology Testing Market by Product, Technology, End-User - Global Forecast to 2024

  • $ 4950
  • June 2019
  • 117 pages

According to The Leukemia & Lymphoma Society (LLS), US, there are ##, ## people living with lymphoma.

  • Leukemia
  • Lymphoma
  • Oncology
  • United States
  • QIAGEN N.V.

Tissue Diagnostics Market by Product, Technology, Disease, End User -Global Forecast to 2025

  • $ 4950
  • May 2020
  • 175 pages

TISSUE DIAGNOSTICS MARKET FOR GASTRIC CANCER, BY REGION, 2018-2025 (USD MILLION) ##. ## LYMPHOMA LYMPHOMA IS A CANCER OF THE IMMUNE SYSTEM.

  • Cancer
  • Diagnostics
  • Lymphoma
  • North America
  • United States

Chromatography Instruments Market by Type, Consumables and Accessories, Applications, and Region - Global Forecast to 2022

  • $ 4950
  • July 2017
  • 246 pages

MarketsandMarkets is a global market research and consulting company.

  • Lymphoma
  • North America
  • United States
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.

In situ Hybridization Market by Technique, Application, & End User - Global Forecast to 2021

  • $ 4950
  • January 2017
  • 194 pages

LYMPHOMA KINASE ADMINISTRACIÓN NACIONAL DE MEDICAMENTOS, ALIMENTOS Y TECNOLOGÍA MÉDICA ASIAN-PACIFIC SOCIETY FOR NEUROCHEMISTRY ADVANCED RESEARCH CENTRE FOR COMPARATIVE BIOETHICS APPLIED SPECTRAL IMAGING AMERICAN SOCIETY FOR MICROBIOLOGY CANADIAN COLLEGE OF MEDICAL GENETICISTS NORTHWESTERN

  • Laboratory
  • Lymphoma
  • United States
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.

North American Nuclear Medicine/Radiopharmaceuticals Market by Type, Application - Forecasts to 2024

  • $ 4950
  • January 2020
  • 156 pages

The emergence of RIT has paved the way for exploring nuclear medicine for treating lymphoma.

  • Lymphoma
  • Nuclear Imaging Equipment
  • North America
  • United States
  • World

Nuclear Imaging Equipment Market by Product, Hybrid PET, Planar Scintigraphy, Application, End user - Global Forecasts to 2021

  • $ 4950
  • January 2017
  • 169 pages

PET-CT scanning is widely accepted as a mainstream diagnostic test for various diseases such as lung cancer, lymphomas, and colorectal carcinoma.

  • Diagnostic Imaging
  • Lymphoma
  • Nuclear Imaging Equipment
  • North America
  • United States

Nuclear Medicine/Radiopharmaceuticals Market by Type, Application - Global Forecast to 2024

  • $ 4950
  • January 2020
  • 231 pages

THE EMERGENCE OF RIT HAS PAVED THE WAY FOR EXPLORING NUCLEAR MEDICINE FOR TREATING LYMPHOMA.

  • Lymphoma
  • Nuclear Imaging Equipment
  • North America
  • United States
  • GE Healthcare Limited

Regenerative Medicine Market by Type, Applications, Region - Global Forecast to 2024

  • $ 4950
  • March 2019
  • 108 pages

The cell-based immunotherapy & cell therapy products segment is further segmented into allogeneic Kite Pharma/ Gilead (US) Cell-based immunotherapy (CAR T-cell therapy) Treatment of B-cell malignancies such as non-Hodgkin lymphoma, acute lymphoblastic leukemia, mantle cell

  • Cell Therapy
  • Lymphoma
  • Medical Biotechnology
  • Regenerative Medicine
  • United States

Particle Therapy Market by Type, Products, Services, System, Cancer Type, Application - Forecast to 2023

  • $ 4950
  • November 2018
  • 139 pages

This segment includes lymphoma, sarcoma, spine cancer, pancreatic cancer, brain cancer, secondary/ reoccurring cancer, and gastrointestinal cancer, among others.

  • Cancer
  • Lymphoma
  • North America
  • United States
  • Varian Medical Systems, Inc.

Immunotherapy Drugs Market by Type, Therapy Area, End User - Global Forecast to 2025

  • $ 4950
  • May 2020
  • 177 pages

THE EC GRANTED MARKETING AUTHORIZATION FOR THE THERAPEUTIC USE OF YESCARTA IN ADULT PATIENTS SUFFERING FROM RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AND PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL) IN ## EU COUNTRIES.

  • Cancer
  • Immunotherapy
  • Lymphoma
  • North America
  • United States

Gene Therapy Market by Vectors, Indication, Delivery Method, Region - Global Forecast to 2024

  • $ 4950
  • January 2020
  • 136 pages

Currently, the company has four drug candidates in the pipeline, three for treating multiple myeloma and one for treating lymphoma.

  • Gene Therapy
  • Lymphoma
  • Medical Biotechnology
  • North America
  • United States

European Nuclear Medicine/Radiopharmaceuticals Market by Type, Therapeutic, by Application - Forecasts to 2020

  • $ 4950
  • November 2015
  • 197 pages

Some of these limitations include low spatial resolution, low sensitivity for detection of hepatic and/ or splenic lymphoma involvement due to physiological uptake in organs, and low accumulation in low-grade lymphoma.

  • Lymphoma
  • Nuclear Imaging Equipment
  • Nuclear Power
  • Europe
  • World

ATP Assay Market by Product, Application, End User, Region - Global Forecast to 2024

  • $ 4950
  • October 2019
  • 165 pages

The newly registered cases (leukemia, lymphoma, and myeloma) accounted for ##. ##% of the total ##. ## million new cancer cases in the US.

  • Lymphoma
  • North America
  • United States
  • World
  • Thermo Fisher Scientific, Inc.
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on